Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
At Incyte Corporation (NASDAQ:INCY), a filing with the SEC revealed that on Thursday, Director Paul A. Brooke bought 50,000 shares of INCY, at a cost of $17.70 each, for a total investment of $884,750. Incyte Corporation is trading up about 5.7% on the day Monday.
And also on Thursday, EVP of Operations Finance Kerrin E. Gillespie bought $152,497 worth of Health Management Associates, Inc. (NYSE:HMA), buying 25,000 shares at a cost of $6.10 a piece. This buy marks the first one filed by Gillespie in the past twelve months. Health Management Associates, Inc. is trading up about 2.1% on the day Monday. Gillespie was up about 6.4% on the purchase at the high point of today's trading session, with HMA trading as high as $6.49 at last check today.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.